XML 91 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Information (Condensed Consolidated Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Cash flows from operating activities:    
Net income (loss) $ 10,563 $ (12,458)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity in income (loss) of unconsolidated joint ventures (2,584) (656)
Change in assets and liabilities:    
Receivables (10,221) 326
Inventories (205,037) (198,761)
Accounts payable, accrued expenses and other liabilities (14,514) (2,413)
Net cash used in operating activities (221,063) (211,032)
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures (8,618) (304)
Proceeds from Sale of Equity Method Investments 10,110 0
Purchases of property and equipment, net (1,576) (430)
Payments for (Proceeds from) Intercompany Transactions, Investing Activities 0 0
Net cash provided by (used in) investing activities (84) (734)
Cash flows from financing activities:    
Change in restricted cash (177) (2,257)
Proceeds from issuance of debt 0 230,000
Payment of debt issuance costs 0 (6,878)
Payments on mortgages and land contracts due to land sellers and other loans (2,655) (17,003)
Proceeds from issuance of common stock, net 0 109,811
Issuance of common stock under employee stock plans 0 52
Payments of cash dividends (2,094) (2,089)
Intercompany 0 0
Net cash provided by (used in) financing activities (4,926) 311,636
Net increase (decrease) in cash and cash equivalents (226,073) 99,870
Cash and cash equivalents at beginning of period 532,523 525,688
Cash and cash equivalents at end of period 306,450 625,558
KB Home Corporate
    
Cash flows from operating activities:    
Net income (loss) 10,563 (12,458)
Change in assets and liabilities:    
Net cash used in operating activities   8,208
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures 0 0
Proceeds from Sale of Equity Method Investments 0  
Purchases of property and equipment, net (70) (96)
Payments for (Proceeds from) Intercompany Transactions, Investing Activities (265,497) (239,211)
Net cash provided by (used in) investing activities (265,567) (239,307)
Cash flows from financing activities:    
Change in restricted cash (177) (2,257)
Proceeds from issuance of debt   230,000
Payment of debt issuance costs   (6,878)
Payments on mortgages and land contracts due to land sellers and other loans 0 0
Proceeds from issuance of common stock, net   109,811
Issuance of common stock under employee stock plans   52
Payments of cash dividends (2,094) (2,089)
Intercompany 0 0
Net cash provided by (used in) financing activities (2,271) 328,639
Net increase (decrease) in cash and cash equivalents (242,613) 97,540
Cash and cash equivalents at beginning of period 476,847 457,007
Cash and cash equivalents at end of period 234,234 554,547
Guarantor Subsidiaries
    
Cash flows from operating activities:    
Net income (loss) 4,908 (12,322)
Change in assets and liabilities:    
Net cash used in operating activities   (206,425)
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures (8,618) (94)
Proceeds from Sale of Equity Method Investments 10,110  
Purchases of property and equipment, net (1,455) (318)
Payments for (Proceeds from) Intercompany Transactions, Investing Activities 0 0
Net cash provided by (used in) investing activities 37 (412)
Cash flows from financing activities:    
Change in restricted cash 0 0
Proceeds from issuance of debt   0
Payment of debt issuance costs   0
Payments on mortgages and land contracts due to land sellers and other loans (2,655) (17,003)
Proceeds from issuance of common stock, net   0
Issuance of common stock under employee stock plans   0
Payments of cash dividends 0 0
Intercompany 260,828 230,182
Net cash provided by (used in) financing activities 258,173 213,179
Net increase (decrease) in cash and cash equivalents 19,727 6,342
Cash and cash equivalents at beginning of period 41,316 54,205
Cash and cash equivalents at end of period 61,043 60,547
Non-Guarantor Subsidiaries
    
Cash flows from operating activities:    
Net income (loss) (382) 977
Change in assets and liabilities:    
Net cash used in operating activities   (12,815)
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures 0 (210)
Proceeds from Sale of Equity Method Investments 0  
Purchases of property and equipment, net (51) (16)
Payments for (Proceeds from) Intercompany Transactions, Investing Activities 0 0
Net cash provided by (used in) investing activities (51) (226)
Cash flows from financing activities:    
Change in restricted cash 0 0
Proceeds from issuance of debt   0
Payment of debt issuance costs   0
Payments on mortgages and land contracts due to land sellers and other loans 0 0
Proceeds from issuance of common stock, net   0
Issuance of common stock under employee stock plans   0
Payments of cash dividends 0 0
Intercompany 4,669 9,029
Net cash provided by (used in) financing activities 4,669 9,029
Net increase (decrease) in cash and cash equivalents (3,187) (4,012)
Cash and cash equivalents at beginning of period 14,360 14,476
Cash and cash equivalents at end of period 11,173 10,464
Consolidating Adjustments
    
Cash flows from operating activities:    
Net income (loss) (4,526) 11,345
Change in assets and liabilities:    
Net cash used in operating activities   0
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures 0 0
Purchases of property and equipment, net 0 0
Payments for (Proceeds from) Intercompany Transactions, Investing Activities 265,497 239,211
Net cash provided by (used in) investing activities 265,497 239,211
Cash flows from financing activities:    
Change in restricted cash 0 0
Proceeds from issuance of debt   0
Payment of debt issuance costs   0
Payments on mortgages and land contracts due to land sellers and other loans 0 0
Proceeds from issuance of common stock, net   0
Issuance of common stock under employee stock plans   0
Payments of cash dividends 0 0
Intercompany (265,497) (239,211)
Net cash provided by (used in) financing activities (265,497) (239,211)
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0